Original Article

Journal of Investigative Dermatology (1990) 94, 135s–140s; doi:10.1111/1523-1747.ep12876121

Role of Growth Factors, Cytokines, and Their Receptors in the Pathogenesis of Psoriasis

James G Krueger, Jeffrey F Krane, D Martin Carter and Alice B Gottlieb

Rockefeller University, New York, New York, U.S.A.

Top

Abstract

Psoriasis is characterized by epidermal hyperplasia, altered epidermal maturation, and local accumulation of acute and chronic inflammatory cells. Keratinocyte hyperplasia in psoriasis may be explained in part by overproduction of growth factors or cytokines which stimulate epidermal proliferation and by altered metabolism of growth-factor receptors in affected skin. Psoriatic epidermis displays overproduction of TGF-alpha and interleukin-6 (IL-6), factors produced by keratinocytes and other cell types in psoriatic skin. TGF-alpha and IL-6 are mitogens for normal human keratinocytes and act via specific receptors. The TGF-alpha receptor (EGF receptor) is overexpressed in psoriatic epithelium and its altered expression could be caused in part by gamma interferon which prevents normal receptor down-regulation in response to EGF binding. Several phenotypic features of the psoriatic keratinocyte, including growth activation and expression of HLA-DR, gamma-IP-10, ICAM-1, and other molecules, are best explained as resulting from the combined effects of TGF-alpha, IL-6, and gamma interferon (and possibly other cytokines) on epidermal keratinocytes. The multiple histologic features of psoriasis, including epidermal hyperplasia and accumulation of acute and chronic inflammatory cells, may be mediated by defined growth factors and cytokines that are produced in psoriatic skin and affect the function of diverse cell types.

Top

References

  1. Gottlieb, AB, Lifshitz, B, Fu, SM, Staiano-Coico, L, Wang, CY, Carter, DM: Expression of HLA-DR molecules by keratinocytes, and the presence of langerhans cells in the dermal infiltrate of active psoriatic plaques. J Exp Med 1986 164: 1013–1028,  | Article | PubMed | ISI | ChemPort |
  2. Gottlieb, AB, Luster, AD, Posnett, DN, Carter, DM: Detection of a (gamma) interferon-induced protein IP-10 in psoriatic plaques. J Exp Med 1988 168: 941–948,  | Article | PubMed | ISI | ChemPort |
  3. Griffiths, CEM, Voorhees, JJ, Nickoloff, BJ: Characterization of intercellular adhesion molecule-1 and HLA-DR expression in normal and inflamed skin: Modulation by recombinant gamma interferon and tumor necrosis factor. J Am Acad Dermatol 1989 20: 617–629,  | PubMed | ISI | ChemPort |
  4. Gottlieb, AB: Immunologic mechanisms in psoriasis. J Am Acad Dermatol 1988 18: 1376–1380,  | PubMed | ISI | ChemPort |
  5. Luster, AD, Ravetch, JV: Biochemical characterization of (gamma) interferon-inducible cytokine (IP-10). J Exp Med 1987 166: 1084–1097,  | Article | PubMed | ISI | ChemPort |
  6. Nickoloff, BJ, Basham, TY, Merigan, TC, Morhenn, VB: Antiproliferative effects of recombinant (alpha)- and (gamma)-interferons on cultured human keratinocytes. Lab Invest 1984 51: 697–701,  | PubMed | ISI | ChemPort |
  7. Kupper, TS: The immunophysiology of cells and cytokines. The role of epidermal cytokines Oppenheim J, Shevach E (ed.). Oxford University Press, Oxford (in press)
  8. Hancock, GE, Kaplan, G, Cohn, ZA: Keratinocyte growth regulation by the products of immune cells. J Exp Med 1988 168: 1395–1402,  | Article | PubMed | ISI | ChemPort |
  9. Grossman, RM, Krueger, J, Yourish, D, Granelli-Peperno, A, Murphy, DP, May, LT, Kupper, TS, Sehgal, PB, Gottlieb, AB: Interleukin 6 is expressed in high levels in psoriatic skin and stimulates proliferation of cultured human keratinocytes. Proc Natl Acad Sci USA 1989 86: pp 6367–6371,  | Article | PubMed | ChemPort |
  10. Cohen, S, Elliott, GA: The stimulation of epidermal keratinization by a protein isolated from the submaxillary gland of the mouse. J Invest Dermatol 1963 40: 1–5,  | PubMed | ChemPort |
  11. Barrandon, Y, Green, H: Cell migration is essential for sustained growth of keratinocyte colonies: The roles of transforming growth factor-(alpha) and epidermal growth factor. Cell 1987 50: 1131–1137,  | Article | PubMed | ISI | ChemPort |
  12. Carpenter, G, Cohen, S: Epidermal growth factor. Ann Rev Biochem 1979 48: 193–216,  | Article | PubMed | ISI | ChemPort |
  13. King, LE: What does epidermal growth factor do and how does it do it? J Invest Dermatol 1985 84: 165–167,
  14. Gottlieb, AB, Chang, CK, Posnett, DN, Fanelli, B, Tam, JP: Detection of transforming growth factor (alpha) in normal, malignant, and hyperproliferative human keratinocytes. J Exp Med 1988 167: 670–675,  | Article | PubMed | ISI | ChemPort |
  15. Coffey, RJ, Derynck, R, Wilcox, JN, Bringman, TS, Goustin, AS, Moses, HL, Pittelkow, MR: Production and autoinduction of transforming growth factor-(alpha) in human keratinocytes. Nature (London) 1987 328: 817–823,  | Article | ChemPort |
  16. Bjorge, JD, Paterson, AJ, Kudlow, JE: Phorbol ester or epidermal growth factor (EGF) stimulates the concurrent accumulation of mRNA for the EGF receptor and its ligand transforming growth factor-(alpha) in a breast cancer cell line. J Biol Chem 1989 264: 4021–4027,  | PubMed |
  17. Krueger, J, Krane, J, Gottlieb, AB, Yourish, D, Sehgal, P, May, L, Decker, S, Kupper, T: Cytokine modulation of epithelial function: contrasting effects of interleukin 6/B2-interferon and gamma-interferon on human keratinocyte growth and differentiation (abstr). J Invest Dermatol 1989 92: 464,
  18. Pledger, WJ, Stiles, CD, Antoniades, HN, Scher, CD: An ordered sequence of events is required before BALB/c-3T3 cells become committed to DNA synthesis. Proc Natl Acad Sci USA 1978 75: 2839–2843,  | PubMed |
  19. Elder, JT, Fisher, GJ, Lindquist, PB, Bennett, GL, Pittelkow, GL, Coffey, RJ, Ellingsworth, L, Derynck, R, Voorhees, JJ: Overexpression of transforming growth factor (alpha) in psoriatic epidermis. Science 1989 243: 811–814,  | PubMed | ISI | ChemPort |
  20. Nanney, LB, Stoscheck, CM, Magid, M, King, LE: Altered epidermal growth factor binding and receptor distribution in psoriasis. J Invest Dermatol 1986 86: 260–265,  | Article | PubMed | ISI | ChemPort |
  21. Gentleman, S, Martensen, TM, Digiovanna, JJ, Chader, GJ: Protein tyrosine kinase and protein phosphotyrosine phosphatase in normal and psoriatic skin. Biochem Biophys Acta 1984 798: 53–59,
  22. Bartel, RL, Marcelo, CL, Voorhees, JJ: Partial characterization of phospholipase activity in normal, psoriatic uninvolved, and lesional epiderms. J Invest Dermatol 1987 88: 447–451,  | Article | PubMed | ChemPort |
  23. Horn, F, Marks, F, Fisher, GJ, Marcelo, CL, Voorhees, JJ: Decreased protein kinase activity in psoriatic versus normal epidermis. J Invest Dermatol 1987 88: 220–222,  | Article | PubMed | ISI | ChemPort |
  24. Neuner, P, Kapp, A, Kirnbauer, R, Schwarz, T, Krutmann, J, Luger, TA: Monocytes derived from patients with psoriasis synthesize and release increased levels of interleukin 6 (abstr). J Invest Dermatol 1989 92: 490,
  25. Hammerberg, C, Fisher, G, Baadsgaard, O, Voorhees, JJ, Cooper, KD: Characterization of IL-1 and inhibitor in psoriatic skin and normal skin. J Invest Dermatol 1989 92: 439,
  26. Kupper, TS, Blanton, B, Wong, D, Sims, J, Dower, S: The keratinocyte interleukin 1 receptor: Molecular, biochemical, and functional analysis. J Invest Dermatol 1989 92: 466,
  27. Baadsgaard, O, Fisher, G, Fox, DA, Salvo, B, Carey, T, Marcello, C, Voorhees, JJ, Cooper, KD: Conditioned media from lesional psoriatic T-cell clones induces keratinocyte proliferation and expression of the surface activation molecule UM4D4 (abstr). J Invest Dermatol 1989 92: 398,
  28. Buchsbaum, ME, Lewis, RE, Kupper, TS, Murphy, GF: Differential induction of intercellular adhesion molecule-1 in human skin by recombinant cytokines (abstr). J Invest Dermatol 1989 92: 408,

Extra navigation

.
ADVERTISEMENT